Active ingredientPolymyxin B SulfateCat. No. P-P153-001CAS 1405-20-5Family · Pharmaceutical analytical standards
Polymyxin B
A polypeptide antibiotic made by the bacterium Paenibacillus polymyxa, discovered in 1947 and approved in the United States in 1964: it disrupts the membranes of Gram-negative bacteria and is now a reserve antibiotic, also used on the skin. This family brings together the active ingredient and other impurities.
Did you know?Fixed onto fibres inside a cartridge, it is used to cleanse the blood in septic shock: the drug stays bound to the fibres and captures the bacterial endotoxin that triggers the shock.
Go to the active ingredient →Active ingredientPolymyxin B SulfateCat. No. P-P153-001CAS 1405-20-5
Active ingredientPolymyxin B1Cat. No. P-P153-002CAS 4135-11-9
Active ingredientPolymyxin B2Cat. No. P-P153-003CAS 34503-87-2
Active ingredientPolymyxin B3Cat. No. P-P153-004CAS 71140-58-4
ImpurityPolymyxin B Impurity 1Cat. No. P-P153-007
ImpurityPolymyxin B1 PentatrifluoroacetateCat. No. P-P153-009
ImpurityPolymyxin B1-ICat. No. P-P153-010CAS 811435-10-6
ImpurityPolymyxin B2 PentatrifluoroacetateCat. No. P-P153-012
ImpurityPolymyxin B3 PentatrifluoroacetateCat. No. P-P153-013
ImpurityPolymyxin B Impurity 2 Sodium SaltCat. No. P-P153-014
ImpurityPolymyxin E2Cat. No. P-P153-018CAS 30387-41-8
ImpurityPolymyxin B Impurity 3Cat. No. P-P153-021No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substancePolymyxin B sulfate CRSEDQM code P2400000Family Polymyxin BReference substancePolymyxin B sulfate for microbiological assay CRSEDQM code Y0000355Family Polymyxin BNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.